JP2019533017A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019533017A5 JP2019533017A5 JP2019540482A JP2019540482A JP2019533017A5 JP 2019533017 A5 JP2019533017 A5 JP 2019533017A5 JP 2019540482 A JP2019540482 A JP 2019540482A JP 2019540482 A JP2019540482 A JP 2019540482A JP 2019533017 A5 JP2019533017 A5 JP 2019533017A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- cysteine
- toxin complex
- thiol group
- cytotoxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 22
- 235000018417 cysteine Nutrition 0.000 claims 22
- 102000004965 antibodies Human genes 0.000 claims 19
- 108090001123 antibodies Proteins 0.000 claims 19
- 239000003053 toxin Substances 0.000 claims 12
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 10
- 101700027111 3SA0 Proteins 0.000 claims 7
- 101700067609 ctx Proteins 0.000 claims 7
- 231100000599 cytotoxic agent Toxicity 0.000 claims 7
- 239000002619 cytotoxin Substances 0.000 claims 7
- 230000000873 masking Effects 0.000 claims 4
- 231100000765 Toxin Toxicity 0.000 claims 3
- 150000001413 amino acids Chemical group 0.000 claims 3
- 238000003780 insertion Methods 0.000 claims 3
- 239000003638 reducing agent Substances 0.000 claims 3
- 238000005277 cation exchange chromatography Methods 0.000 claims 2
- 238000000108 ultra-filtration Methods 0.000 claims 2
- MFRNYXJJRJQHNW-DEMKXPNLSA-N (2S)-2-[[(2R,3R)-3-methoxy-3-[(2S)-1-[(3R,4S,5S)-3-methoxy-5-methyl-4-[methyl-[(2S)-3-methyl-2-[[(2S)-3-methyl-2-(methylamino)butanoyl]amino]butanoyl]amino]heptanoyl]pyrrolidin-2-yl]-2-methylpropanoyl]amino]-3-phenylpropanoic acid Chemical compound CN[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MFRNYXJJRJQHNW-DEMKXPNLSA-N 0.000 claims 1
- 102000004851 Immunoglobulin G Human genes 0.000 claims 1
- DASWEROEPLKSEI-UIJRFTGLSA-N Monomethyl auristatin E Chemical compound CN[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)C1=CC=CC=C1 DASWEROEPLKSEI-UIJRFTGLSA-N 0.000 claims 1
- 230000036462 Unbound Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 238000006011 modification reaction Methods 0.000 claims 1
- 230000001590 oxidative Effects 0.000 claims 1
- 229920002857 polybutadiene Polymers 0.000 claims 1
- 230000001603 reducing Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610876568.9 | 2016-10-08 | ||
| CN201610876568 | 2016-10-08 | ||
| PCT/CN2017/104706 WO2018064964A1 (zh) | 2016-10-08 | 2017-09-30 | 半胱氨酸改造的抗体-毒素偶联物及其制备方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019533017A JP2019533017A (ja) | 2019-11-14 |
| JP2019533017A5 true JP2019533017A5 (ru) | 2020-08-20 |
| JP6998386B2 JP6998386B2 (ja) | 2022-02-10 |
Family
ID=61533952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019540482A Active JP6998386B2 (ja) | 2016-10-08 | 2017-09-30 | システイン改変抗体－毒素複合体及びその製造方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11484605B2 (ru) |
| EP (1) | EP3524273A4 (ru) |
| JP (1) | JP6998386B2 (ru) |
| KR (2) | KR102579211B1 (ru) |
| CN (2) | CN117398475A (ru) |
| AU (1) | AU2017340314B2 (ru) |
| CA (1) | CA3039559A1 (ru) |
| IL (1) | IL265838B2 (ru) |
| RU (1) | RU2762594C2 (ru) |
| SG (1) | SG11201903084UA (ru) |
| WO (1) | WO2018064964A1 (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018288030B2 (en) * | 2017-06-20 | 2022-02-03 | Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. | Screening of fixed-point coupling sites of cysteine-modified antibody-toxin conjugate (TDC) |
| CN110872339A (zh) * | 2018-08-30 | 2020-03-10 | 中国人民解放军军事科学院军事医学研究院 | 含有芳硝基的连接子、含连接子的抗体偶联药物及连接子的用途 |
| KR102440763B1 (ko) * | 2019-05-20 | 2022-09-05 | 맙플렉스 인터내셔널 컴퍼니 리미티드 | 항체-약물 접합체의 중간체를 제조하는 원-포트 방법 |
| WO2024088283A1 (zh) * | 2022-10-26 | 2024-05-02 | 同润生物医药(上海)有限公司 | 人源化的l1cam抗体药物偶联物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005286607B2 (en) | 2004-09-23 | 2011-01-27 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
| CL2008001334A1 (es) * | 2007-05-08 | 2008-09-22 | Genentech Inc | Anticuerpo anti-muc16 disenado con cisteina; conjugado que lo comprende; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso para tratar el cancer. |
| PE20090481A1 (es) * | 2007-07-16 | 2009-05-18 | Genentech Inc | Anticuerpos anti-cd79b e inmunoconjugados humanizados y metodos de uso |
| ES2450755T3 (es) * | 2007-10-19 | 2014-03-25 | Genentech, Inc. | Anticuerpos anti-TENB2 modificados por ingeniería genética con cisteína, y conjugados de anticuerpo y fármaco |
| ES2587392T3 (es) * | 2008-01-31 | 2016-10-24 | Genentech, Inc. | Anticuerpos anti-CD79b e inmunoconjugados y métodos de uso |
| MX2012006406A (es) * | 2009-12-04 | 2012-07-25 | Genentech Inc | Anticuerpos multiespecificos, analogos de anticuerpo, composiciones y metodos. |
| CN105143271A (zh) * | 2013-02-08 | 2015-12-09 | Irm责任有限公司 | 用于修饰抗体以制备免疫缀合物的特定位点 |
| RU2711485C2 (ru) | 2014-04-11 | 2020-01-17 | МЕДИММЬЮН, ЭлЭлСи | Конъюгированные соединения, содержащие сконструированные с цистеином антитела |
| SG10202006863YA (en) | 2015-02-16 | 2020-08-28 | Lonza Ag | Cl and/or ch1 mutated antibodies for drug conjugation |
| CN106467575B (zh) * | 2015-08-18 | 2020-07-31 | 四川百利药业有限责任公司 | 半胱氨酸改造的抗体-毒素偶联物 |
| TWI637966B (zh) * | 2015-11-30 | 2018-10-11 | 輝瑞股份有限公司 | 用於部位專一性接合之抗體和抗體片段 |
| CN106866822A (zh) * | 2016-12-25 | 2017-06-20 | 四川百利药业有限责任公司 | 半胱氨酸改造的抗体‑毒素偶联物 |
-
2017
- 2017-09-29 CN CN202311413663.1A patent/CN117398475A/zh active Pending
- 2017-09-29 CN CN201710910870.6A patent/CN107789630A/zh active Pending
- 2017-09-30 KR KR1020227044769A patent/KR102579211B1/ko active IP Right Grant
- 2017-09-30 CA CA3039559A patent/CA3039559A1/en active Pending
- 2017-09-30 SG SG11201903084UA patent/SG11201903084UA/en unknown
- 2017-09-30 IL IL265838A patent/IL265838B2/en unknown
- 2017-09-30 AU AU2017340314A patent/AU2017340314B2/en active Active
- 2017-09-30 EP EP17857845.6A patent/EP3524273A4/en active Pending
- 2017-09-30 US US16/339,719 patent/US11484605B2/en active Active
- 2017-09-30 WO PCT/CN2017/104706 patent/WO2018064964A1/zh unknown
- 2017-09-30 RU RU2019113758A patent/RU2762594C2/ru active
- 2017-09-30 JP JP2019540482A patent/JP6998386B2/ja active Active
- 2017-09-30 KR KR1020197013122A patent/KR102480873B1/ko active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019533017A5 (ru) | ||
| RU2427590C2 (ru) | Анти-mn антитела и способы их применения | |
| HRP20191462T1 (hr) | Antitijela usmjerena protiv her-3 i njihove uporabe | |
| WO2004010947A3 (en) | Humanized antibodies against human 4-1bb | |
| HRP20191609T1 (hr) | Protein | |
| HRP20141111T1 (hr) | Sastav her2-protutijela | |
| PE20020871A1 (es) | Moleculas de enlace terapeuticas | |
| RS20060234A (en) | Fully human antibodies against human 4-1bb (cd137) | |
| HRP20161050T1 (hr) | Her2/neu specifična protutijela i postupci njihovog korištenja | |
| HRP20221260T1 (hr) | Humanizirana i kimerna monoklonska protutijela za cd47 | |
| RU2010126078A (ru) | Антитело против nr10 и его применение | |
| TNSN06087A1 (en) | Therapeutic binding molecules | |
| ZA200508389B (en) | Humanized antibodies to interferon alpha receptor-1(IFNAR-1) | |
| DK1347730T3 (da) | Rekombinante anti-CD30-antistoffer og anvendelser deraf | |
| RS52332B (en) | HUMAN ANTI-NGF NEUTRAL ANTIBODIES AS SELECTIVE NGF SIGNAL ROUTE INHIBITORS | |
| WO2007115049A3 (en) | Humanized monoclonal antibodies to hepatocyte growth factor | |
| HRP20211444T1 (hr) | Anti-dll3 antitijelo | |
| BRPI0611414B8 (pt) | anticorpo ou fragmento de ligação ao antígeno do mesmo que se liga ao tweak humano, composição farmacêutica e seus usos | |
| WO2002002640A3 (en) | Antibodies to human mcp-1 | |
| RU2019113758A (ru) | Конъюгат "цистеин-модифицированное антитело-лекарственное средство" и способ его получения | |
| SI2970497T1 (en) | Variants of anti-TFPI antibodies with differential binding over the pH range for improved pharmacokinetic properties | |
| PE20121397A1 (es) | Anticuerpos especificos para cadherina-17 | |
| HRP20221298T1 (hr) | Anti-ror2 protutijela, fragmenti protutijela, njihovi imunokonjugati i njihove uporabe | |
| WO2008100563A3 (en) | Compositions and methods for diagnosing and treating cancer | |
| JP2018515449A5 (ru) |